Can nongenotoxic carcinogens be detected with the lacl transgenic mouse mutation assay?

10.1016/0027-5107(89)90196-6

10.1002/em.2850200302

10.1016/0165-1218(88)90114-0

Becker FF, 1982, Morphological classification of mouse liver tumors based on biological characteristics, Cancer Res, 42, 3918

Butterworth BE, 1987, Nongenotoxic Mechanisms in Carcinogenesis, 257

10.1016/0165-1110(90)90033-8

10.1177/030089168607200201

Cohen SM, 1991, Genetic errors, cell proliferation, and carcinogenesis, Cancer Res, 51, 6493

Dietrich DR, 1991, The presence of alpha‐2u‐globulin is necessary for d‐limonene promotion of male rat kidney tumors, Cancer Res, 51, 3512

10.1093/nar/18.10.3007

Littlefield NA, 1980, Effects of dose and time in a long‐term, low‐dose carcinogenic study, J Environ Pathol Toxicol, 3, 17

Loeb LA, 1989, Endogenous carcinogenesis: molecular oncology into the twenty‐first century—Presidential address, Cancer Res, 49, 5489

10.1016/0165-1110(90)90020-C

10.1096/fasebj.6.9.1612294

10.1016/S0304-3835(75)96367-3

Thorpe E, 1973, The toxicology of dieldrin (HEOD*), II. Comparative long‐term oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, beta‐BHC and gamma‐BHC. Fd Cosmet Toxicol, 11, 433